163 related articles for article (PubMed ID: 35116577)
1. Prognostic significance of pyruvate kinase M2 expression in esophageal squamous cell carcinoma and its meta-analysis.
Zhang Q; Zheng S; Liu Q; Liu T; Tuerxun A; Yang L; Han X; Lu X
Transl Cancer Res; 2021 Jun; 10(6):2643-2652. PubMed ID: 35116577
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of metabolic enzyme pyruvate kinase M2 in breast cancer: A meta-analysis.
Yang Y; Wu K; Liu Y; Shi L; Tao K; Wang G
Medicine (Baltimore); 2017 Nov; 96(46):e8690. PubMed ID: 29145305
[TBL] [Abstract][Full Text] [Related]
3. Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: evidence from 16 cohort studies.
Wu J; Hu L; Chen M; Cao W; Chen H; He T
Onco Targets Ther; 2016; 9():4277-88. PubMed ID: 27478385
[TBL] [Abstract][Full Text] [Related]
4. Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Zhang X; He C; He C; Chen B; Liu Y; Kong M; Wang C; Lin L; Dong Y; Sheng H
Pathol Res Pract; 2013 Aug; 209(8):510-5. PubMed ID: 23880164
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
[TBL] [Abstract][Full Text] [Related]
6. SUMOylation of HSP27 regulates PKM2 to promote esophageal squamous cell carcinoma progression.
Zhang X; Liu T; Zheng S; Liu Q; Shen T; Han X; Zhang Q; Yang L; Lu X
Oncol Rep; 2020 Oct; 44(4):1355-1364. PubMed ID: 32945483
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and prognostic significance of programmed cell death ligand 1 (PD-L1) expression in patients with esophageal squamous cell carcinoma: a meta-analysis.
Qu HX; Zhao LP; Zhan SH; Geng CX; Xu L; Xin YN; Jiang XJ
J Thorac Dis; 2016 Nov; 8(11):3197-3204. PubMed ID: 28066599
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and prognostic significance of survivin over-expression in patients with esophageal squamous cell carcinoma: a meta-analysis.
Li C; Li Z; Zhu M; Zhao T; Chen L; Ji W; Chen H; Su C
PLoS One; 2012; 7(9):e44764. PubMed ID: 23028610
[TBL] [Abstract][Full Text] [Related]
9. miR-133b Promotes Esophageal Squamous Cell Carcinoma Metastasis.
Huang CG; Liu Q; Zheng ST; Liu T; Tan YY; Peng TY; Chen J; Lu XM
Clin Med Insights Oncol; 2023; 17():11795549231219502. PubMed ID: 38144543
[TBL] [Abstract][Full Text] [Related]
10. ESRRG-PKM2 axis reprograms metabolism to suppress esophageal squamous carcinoma progression and enhance anti-PD-1 therapy efficacy.
Wang T; Zhu Y; Chen L; Zhang W; Qi H; Shi X; Zhong M; Chen H; Li Q
J Transl Med; 2023 Sep; 21(1):605. PubMed ID: 37679788
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic role of MMP-9 in esophageal squamous cell carcinoma: a meta-analysis.
Zeng R; Duan L; Kong Y; Liang Y; Wu X; Wei X; Yang K
Chin J Cancer Res; 2013 Dec; 25(6):637-45. PubMed ID: 24385690
[TBL] [Abstract][Full Text] [Related]
12. M2 isoform of pyruvate kinase (PKM2) is upregulated in Kazakh's ESCC and promotes proliferation and migration of ESCC cells.
Liu Q; Liang M; Liu T; Vuitton L; Zheng S; Gao X; Lu M; Li X; Sheyhidin I; Lu X
Tumour Biol; 2016 Feb; 37(2):2665-72. PubMed ID: 26404132
[TBL] [Abstract][Full Text] [Related]
13. Vasculogenic Mimicry: A Promising Prognosticator in Head and Neck Squamous Cell Carcinoma and Esophageal Cancer? A Systematic Review and Meta-Analysis.
Hujanen R; Almahmoudi R; Karinen S; Nwaru BI; Salo T; Salem A
Cells; 2020 Feb; 9(2):. PubMed ID: 32102317
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and clinicopathological significance of
Wang Y; Wu Y; Li J; Lai Y; Zhou K; Che G
Ann Transl Med; 2019 Nov; 7(22):669. PubMed ID: 31930070
[TBL] [Abstract][Full Text] [Related]
15. Pyruvate kinase M2 (PKM2) expression correlates with prognosis in solid cancers: a meta-analysis.
Zhu H; Luo H; Zhu X; Hu X; Zheng L; Zhu X
Oncotarget; 2017 Jan; 8(1):1628-1640. PubMed ID: 27911861
[TBL] [Abstract][Full Text] [Related]
16. PKM2-regulated STAT3 promotes esophageal squamous cell carcinoma progression via TGF-β1-induced EMT.
Ma R; Liu Q; Zheng S; Liu T; Tan D; Lu X
J Cell Biochem; 2019 Jul; 120(7):11539-11550. PubMed ID: 30756445
[TBL] [Abstract][Full Text] [Related]
17. Plasma‑derived exosomal pyruvate kinase isoenzyme type M2 accelerates the proliferation and motility of oesophageal squamous cell carcinoma cells.
Yang L; Zheng S; Liu Q; Liu T; Zhang Q; Han X; Tuerxun A; Lu X
Oncol Rep; 2021 Oct; 46(4):. PubMed ID: 34396437
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance and function of the vacuolar H+-ATPase subunit V1E1 in esophageal squamous cell carcinoma.
Son SW; Kim SH; Moon EY; Kim DH; Pyo S; Um SH
Oncotarget; 2016 Aug; 7(31):49334-49348. PubMed ID: 27384996
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of hypoxia-inducible factor-1α in esophageal squamous cell carcinoma: a meta-analysis.
Ping W; Sun W; Zu Y; Chen W; Fu X
Tumour Biol; 2014 May; 35(5):4401-9. PubMed ID: 24425106
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of microvessel density in esophageal squamous cell carcinoma-a systematic review and meta-analysis.
Guo X; Meng X; Liu R
Pathol Res Pract; 2021 Nov; 227():153644. PubMed ID: 34634564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]